(SeaPRwire) –
PRINCETON, N.J. and TOKYO, April 1, 2026 — NJ Bio, Inc. (“NJ Bio”), a premier provider of integrated drug discovery and development services, and Ajinomoto Bio‑Pharma Services (“Aji Bio‑Pharma”), a leading specialist in biopharmaceutical manufacturing and platform technologies, have announced a research partnership. This collaboration is intended to broaden the availability of AJICAP™, Aji Bio‑Pharma’s site‑specific conjugation platform … Continue reading “NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development”
This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content.
Category: Top News, Daily News
SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.